MMG Announces 2011 “Todos Juntos Por La Salud” Initiative
On Feb. 11, 2011, clinical trial patient recruitment and retention organization MMG will host a groundbreaking forum, “Todos Juntos por la Salud” or “All Together for Health,” which will address the state of Hispanic and Latino participation in medical research. Through this seminal initiative, MMG will partner with Hispanic and Latino healthcare community leaders to improve understanding of the research barriers faced by Hispanics and Latinos and identify strategies for overcoming them.
Although Hispanics and Latinos represent 16 percent of the US population, they constitute only 3 percent of the approximately 260,000 Americans who volunteer to participate in medical research each year. With the US Hispanic population expected to triple by 2050, steps need to be taken now to achieve greater Hispanic and Latino representation in medical research.
The forum will feature Hispanic and Latino community leaders and health industry stakeholders who will discuss the root causes behind the disparities in medical research participation, share ideas about what needs to occur to increase engagement, and strategize about how groups can collaborate to achieve these goals. Forum outcomes will be publicized to raise awareness, promote best practices, and build on the initiative’s momentum.
“We at MMG feel an urgency to address the disparity in clinical research access and participation among the US Hispanic and Latino populations,” said MMG CEO John Benbrook. “MMG is committed to applying our relationships and insights from our daily work to leading efforts that will get at the heart of these issues and drive tangible change."
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
